We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Fox Class A
FOXA
$24.6B
| $54.8M | 0.5% |
+1,752,337
| New | +$53.2M |
|
52
Arcus Biosciences
RCUS
$3.47B
| $54.4M | 0.5% |
2,883,657
+1,846,375
| +178% | +$31.9M |
|
53
Vishay Intertechnology
VSH
$5.43B
| $52.5M | 0.48% |
2,316,804
+994,602
| +75% | +$22.1M |
|
54
Sysco
SYY
$40.7B
| $52.3M | 0.48% |
+644,544
| New | +$50.8M |
|
55
Johnson Controls International
JCI
$88.7B
| $52M | 0.48% |
796,259
-535,388
| -40% | -$31.2M |
|
56
Icon
ICLR
$12.2B
| $51.7M | 0.48% |
+153,962
| New | +$45.4M |
|
57
Keros Therapeutics
KROS
$200M
| $50.4M | 0.46% |
761,700
+177,908
| +30% | +$10.5M |
|
58
DuPont de Nemours
DD
$19.1B
| $49.2M | 0.45% |
511,204
+405,756
| +385% | +$36.1M |
|
59
Krystal Biotech
KRYS
$9.25B
| $49M | 0.45% |
275,455
-206,524
| -43% | -$28.7M |
|
60
Ameriprise Financial
AMP
$48.8B
| $48.7M | 0.45% |
+111,140
| New | +$44.5M |
|
61
HubSpot
HUBS
$12.3B
| $47.4M | 0.44% |
75,698
-55,833
| -42% | -$33.6M |
|
62
Apogee Therapeutics
APGE
$10.1B
| $46.7M | 0.43% |
702,421
+376,319
| +115% | +$16.4M |
|
|
ANSS
63
DELISTED
Ansys
ANSS
| $46.6M | 0.43% |
134,239
+108,317
| +418% | +$36.7M |
|
64
Edwards Lifesciences
EW
$51.1B
| $46.1M | 0.42% |
481,926
+180,214
| +60% | +$15.1M |
|
65
Equitable Holdings
EQH
$13.1B
| $45.4M | 0.42% |
+1,194,736
| New | +$40.6M |
|
|
X
66
DELISTED
US Steel
X
| $45.1M | 0.42% |
1,105,999
+645,999
| +140% | +$29.6M |
|
67
Cooper Companies
COO
$14.5B
| $44.9M | 0.41% |
442,453
+146,441
| +49% | +$14.2M |
|
68
Supernus Pharmaceuticals
SUPN
$2.67B
| $44M | 0.41% |
+1,291,291
| New | +$38.4M |
|
69
Amgen
AMGN
$204B
| $43.3M | 0.4% |
152,153
+6,153
| +4% | +$1.8M |
|
70
Fortive
FTV
$18B
| $43.2M | 0.4% |
+666,455
| New | +$40.5M |
|
|
SWTX
71
DELISTED
SpringWorks Therapeutics
SWTX
| $42.7M | 0.39% |
867,224
+65,042
| +8% | +$3.01M |
|
72
Bristol-Myers Squibb
BMY
$134B
| $41.7M | 0.38% |
769,254
+156
| +0% | +$7.95K |
|
73
Immunovant
IMVT
$7.91B
| $41.7M | 0.38% |
1,289,504
+539,238
| +72% | +$19.7M |
|
74
Zai Lab
ZLAB
$2.05B
| $41.6M | 0.38% |
2,596,836
+578,309
| +29% | +$12.2M |
|
75
RTX Corp
RTX
$292B
| $41.6M | 0.38% |
426,471
+184,840
| +76% | +$16.7M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.